Reglitazar

CAS No. 170861-63-9

Reglitazar( —— )

Catalog No. M34392 CAS No. 170861-63-9

Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Reglitazar
  • Note
    Research use only, not for human use.
  • Brief Description
    Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
  • Description
    Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    170861-63-9
  • Formula Weight
    392.4
  • Molecular Formula
    C22H20N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1ONC(=O)C1CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pioglitazone hydroch...

    Pioglitazone hydrochloride can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue.

  • Benzo[b]thiophene-7-...

    Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)- is a dual PPARα/γ agonist with EC50 of 0.358μM and 1.21μM.

  • Clofibric acid

    Clofibric acid is a PPARα agonist and hypolipidemic agent.